Amino Acid Compounds and Methods of Use (2019)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 62/690,933, filed Jun 27, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,793,564 | Amino Acid Compounds and Methods of Use In force · High confidence UsedRemaining | Pliant Therapeutics, Inc. | In force | High confidence | ||
| US 11,560,376 | Amino Acid Compounds and Methods of Use In force · High confidence | Pliant Therapeutics, Inc. | In force | High confidence | ||
| Application 18/084,307 | Amino Acid Compounds and Methods of Use Abandoned Abandoned Sep 19, 2024 | Pliant Therapeutics, Inc. | Abandoned | Abandoned Sep 19, 2024 | ||
| Application 18/885,075 | Amino Acid Compounds and Methods of Use Pending Not granted | Pliant Therapeutics, Inc. | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Pliant Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.